LABT Share Price Performance
US$3.66
-4.99 (-57.69%)
Price US$3.66
Share Pricen/a
Lakewood-Amedex Biotherapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
LABT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Lakewood-Amedex Biotherapeutics, Inc. Key Details
About LABT
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin® class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. Lakewood-Amedex Biotherapeutics, Inc. was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June, 2025. The company was incorporated in 2006 and is headquartered in University Park, Florida.
Recent LABT News & Updates
No updates
